FI935264A - Stabiliserade superoxid-dismutas(SOS)-sammansaettningar - Google Patents

Stabiliserade superoxid-dismutas(SOS)-sammansaettningar Download PDF

Info

Publication number
FI935264A
FI935264A FI935264A FI935264A FI935264A FI 935264 A FI935264 A FI 935264A FI 935264 A FI935264 A FI 935264A FI 935264 A FI935264 A FI 935264A FI 935264 A FI935264 A FI 935264A
Authority
FI
Finland
Prior art keywords
stabiliserade
dismutas
sammansaettningar
superoxid
sos
Prior art date
Application number
FI935264A
Other languages
English (en)
Other versions
FI935264A0 (fi
Inventor
Reiner Meyer
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of FI935264A0 publication Critical patent/FI935264A0/fi
Publication of FI935264A publication Critical patent/FI935264A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A61K38/446—Superoxide dismutase (1.15)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0089—Oxidoreductases (1.) acting on superoxide as acceptor (1.15)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y115/00—Oxidoreductases acting on superoxide as acceptor (1.15)
    • C12Y115/01—Oxidoreductases acting on superoxide as acceptor (1.15) with NAD or NADP as acceptor (1.15.1)
    • C12Y115/01001—Superoxide dismutase (1.15.1.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
FI935264A 1992-11-27 1993-11-26 Stabiliserade superoxid-dismutas(SOS)-sammansaettningar FI935264A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4239877A DE4239877C1 (de) 1992-11-27 1992-11-27 Stabilisierte Superoxid-Dismutase (SOD)-Zusammensetzung

Publications (2)

Publication Number Publication Date
FI935264A0 FI935264A0 (fi) 1993-11-26
FI935264A true FI935264A (fi) 1994-05-28

Family

ID=6473780

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935264A FI935264A (fi) 1992-11-27 1993-11-26 Stabiliserade superoxid-dismutas(SOS)-sammansaettningar

Country Status (16)

Country Link
US (1) US5464614A (fi)
EP (1) EP0599262A3 (fi)
JP (1) JPH06199691A (fi)
KR (1) KR940011014A (fi)
AU (1) AU671495B2 (fi)
CA (1) CA2110087A1 (fi)
DE (1) DE4239877C1 (fi)
FI (1) FI935264A (fi)
HU (1) HUT65580A (fi)
IL (1) IL107754A (fi)
MX (1) MX9307433A (fi)
NO (1) NO934289L (fi)
NZ (1) NZ250285A (fi)
PH (1) PH30788A (fi)
TW (1) TW252046B (fi)
ZA (1) ZA938848B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719479B1 (fr) * 1994-05-04 1996-07-26 Sanofi Elf Formulation stable lyophilisée comprenant une protéine: kit de dosage.
US5876992A (en) * 1996-07-03 1999-03-02 Molecular Biology Resources, Inc. Method and formulation for stabilization of enzymes
US6132712A (en) * 1996-12-11 2000-10-17 A. Glenn Braswell Superoxide dismutase stabilized with fragments of casein and pharmaceutical compositions incorporating same
US20040132653A1 (en) * 1997-01-30 2004-07-08 Biopharm Gmbh Lyophilized composition of bone morphogenetic factor human MP52
CA2278546C (en) * 1997-01-30 2008-04-01 Hoechst Marion Roussel Ltd. Freeze-dried composition of bone morphogenetic protein human mp52
WO2003000853A2 (en) * 2001-06-20 2003-01-03 Caprion Pharmaceuticals Inc. Protein aggregation assays and uses thereof
DE10223783A1 (de) * 2002-05-29 2003-12-11 Boehringer Ingelheim Pharma Neue Formulierung zur parenteralen Applikation eines Na-Kanal-Blockers
US8318803B2 (en) * 2003-10-31 2012-11-27 Tae-Yoon Kim EC SOD and use thereof
JP4891083B2 (ja) 2003-10-31 2012-03-07 テー−ヨーン キム Ｅｃｓｏｄ及び細胞侵透性ｅｃｓｏｄとこれらの用途
KR101010055B1 (ko) * 2008-06-16 2011-01-21 한국전력공사 디스크 유량계 및 그의 제어방법
EP2483407A2 (en) 2009-09-30 2012-08-08 President and Fellows of Harvard College Methods for modulation of autophagy through the modulation of autophagy-enhancing gene products
WO2014064637A1 (en) * 2012-10-26 2014-05-01 Lupin Limited Stable pharmaceutical composition of tnfr:fc fusion protein
EP3091069A1 (en) * 2015-05-06 2016-11-09 Fitoplancton Marino S.L. Method for obtaining a biomass of a microalga of the species tetraselmis chuii enriched in superoxide dismutase (sod)

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5712993A (en) * 1980-06-23 1982-01-22 Fujirebio Inc Isolation of superoxide dismutase
IT1142524B (it) * 1981-05-27 1986-10-08 Serono Ist Farm Composizione farmaceutica contenente orgoteina
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
US4447355A (en) * 1982-04-07 1984-05-08 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing a tumor necrosis factor and a stable aqueous solution or powder containing the same
EP0123291A2 (en) * 1983-04-20 1984-10-31 Kyowa Hakko Kogyo Co., Ltd. Method for stabilizing interferon
EP0138111B1 (en) * 1983-10-03 1991-11-21 Chiron Corporation Superoxide dismutase cloning and expression in microorganisms
JPS60155133A (ja) * 1983-11-09 1985-08-15 シンビオテイツクス　コ−ポレイシヨン アンチ−イデイオタイプのモノクロナル抗体を採用したアンチ−イデイオタイプワクチン
JPS60228422A (ja) * 1984-04-26 1985-11-13 Suntory Ltd 安定化された生理活性物質製剤
CA1340597C (en) * 1984-08-27 1999-06-22 Haim Aviv Expression vectors containing pl promoter, and engineered restriction site for convenient replacement of ribosomal binding site, plasmids containing the vectors, hosts containing the plasmids and related methods
JPS61111690A (ja) * 1984-11-06 1986-05-29 Ube Ind Ltd 組換えｄｎａおよびその用途
CA1232850A (en) * 1985-01-17 1988-02-16 Albert D. Friesen Purification of superoxide dismutase
ES8800982A1 (es) * 1985-07-05 1987-12-01 Takeda Chemical Industries Ltd Un metodo para producir la enzima superoxido-dismutasa modificada con derivados de polietilenglicol y triazina.
DK402785D0 (da) * 1985-09-03 1985-09-03 Syn Tek Ab Fremgangsmaade til fremstilling af et enzym
JPS6279778A (ja) * 1985-10-04 1987-04-13 Suntory Ltd 新規ス−パ−オキシドデイスムタ−ゼ及びその製造方法
IE59498B1 (en) * 1985-11-22 1994-03-09 Bio Technology General Corp Human manganese superoxide dismutase analog, plasmid for its expression and method of recovering it in enzymatically active form
US5246847A (en) * 1985-11-22 1993-09-21 Bio-Technology General Corp. Polypeptide analogs of human manganese superoxide dismutase and compositions and complexes thereof
US4933433A (en) * 1986-01-31 1990-06-12 E. I. Du Pont De Nemours And Company Recombinant interleukin-2 composition and process for making it
US5260204A (en) * 1987-03-14 1993-11-09 Boehringer Ingelheim International Gmbh Human manganese superoxide dismutase (hMn-SOD)
EP0691401A1 (en) * 1987-03-27 1996-01-10 Bio-Technology General Corporation Human manganese superoxide dismutase analogs, pharmaceutical compositions containing them, and use thereof
DE3851257T4 (de) * 1987-05-21 1996-07-11 Suntory Ltd Azyliertes Derivat von Superoxid-Dismutase und dieses enthaltende Zusammensetzung.
US4895716A (en) * 1987-06-09 1990-01-23 Biogen, Inc. Stabilized formulations of gamma interferons
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
JPH01304882A (ja) * 1988-06-03 1989-12-08 Ube Ind Ltd ヒトＣｕ，Ｚｎ型スーパーオキシドジスムターゼの安定保存法
EP0416037B1 (en) * 1988-06-14 1995-07-26 Chiron Corporation Superoxide dismutase analogs having novel binding properties
JPH0610138B2 (ja) * 1988-07-12 1994-02-09 日本化薬株式会社 スーパーオキシドディスムターゼ組成物
US5538878A (en) * 1988-08-08 1996-07-23 Calgene, Inc. Superoxide dismutase expression in plants
EP0359617A3 (en) * 1988-09-02 1990-04-04 Plant Genetic Systems, N.V. Stress-tolerant plants
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
IL96136A (en) * 1989-11-07 2000-12-06 Bio Technology General Corp Use of hydrophobic chromatography in a method for purification of copper-zinc superoxide dismutase from cells containing same
JPH0568541A (ja) * 1990-12-28 1993-03-23 Asahi Chem Ind Co Ltd 活性なエクストラセルラー・スーパーオキシドジスムターゼの製造方法
US5298410A (en) * 1993-02-25 1994-03-29 Sterling Winthrop Inc. Lyophilized formulation of polyethylene oxide modified proteins with increased shelf-life

Also Published As

Publication number Publication date
AU671495B2 (en) 1996-08-29
CA2110087A1 (en) 1994-05-28
JPH06199691A (ja) 1994-07-19
HU9303365D0 (en) 1994-03-28
ZA938848B (en) 1995-04-06
NO934289L (no) 1994-05-30
EP0599262A3 (de) 1994-11-23
NZ250285A (en) 1995-04-27
HUT65580A (en) 1994-07-28
KR940011014A (ko) 1994-06-20
IL107754A0 (en) 1994-02-27
AU5195393A (en) 1994-06-09
US5464614A (en) 1995-11-07
FI935264A0 (fi) 1993-11-26
IL107754A (en) 1996-10-16
PH30788A (en) 1997-10-17
DE4239877C1 (de) 1994-03-17
MX9307433A (es) 1994-08-31
TW252046B (fi) 1995-07-21
EP0599262A2 (de) 1994-06-01
NO934289D0 (no) 1993-11-26

Similar Documents

Publication Publication Date Title
NO922557D0 (no) Spyleverktoey
AT399443B (de) Sportschuh
FI935264A (fi) Stabiliserade superoxid-dismutas(SOS)-sammansaettningar
BR9305745A (pt) Quebra-luz
DE59301902D1 (de) Kassenlade
ATA236892A (de) Rotornut
NO931650D0 (no) Isbryter
ATA227792A (de) Sportschuh
BR9301712A (pt) Aplainador
FIU920454U0 (fi) Raeddningsanordning
DE59301762D1 (de) Chlorethylsulfonylbenzaldehyde
SE9202239L (sv) Emanuelle II
BR9202399A (pt) Jifo ii
FI416U1 (fi) Backhoppsleksak
DE59206388D1 (de) Kabeleckkanal
FI571U1 (fi) Stockvaegg
ATA25994A (de) Alpinski
BR7201859U (pt) Cambao
ATA27393A (de) Alpinski
BR9204204A (pt) Gabanto
ATA256392A (de) Bandräumer
BR9204368A (pt) Auto-coletor
BR7200240U (pt) Vari-watt
BR9200298A (pt) Microsisten-telesupervisao
BR7200318U (pt) Cabide sanfonado

Legal Events

Date Code Title Description
FD Application lapsed